STAT+: Pharmalittle: State Medicaid programs seek discounts for Wegovy; congressional PBM bills work around the fringes
Top of the morning to you. And a fine one it is. Lots of sunshine…
Category: Pharma
STAT+: South Africa faces court hearing over opaque Covid-19 vaccine contracts
A hearing began in a South Africa court on Tuesday to determine whether the government…
.jpg)
STAT+: Pharmalittle: Biogen to slash 1,000 more jobs; key House panel proposes lowering Medicare out-of-pocket drug costs
Rise and shine, everyone, another busy day is on the way. This morning is getting…
STAT+: Pharmalittle: Three big drugmakers spent less on lobbying after leaving PhRMA; EMA reviews CRO over data concerns
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
.jpg)
STAT+: Pfizer says most tornado damage at key plant hit warehouse, but finished drugs also impacted
Pfizer says a tornado that ripped through a key manufacturing plant in North Carolina does…
STAT+: Major pharma companies call on their suppliers to reduce carbon footprints
As anxiety mounts over climate change, seven of the world’s largest drugmakers urged dozens of…
STAT+: European regulator will review study data from contract research organization due to ‘serious concerns’
In the latest melee over the safety of prescription medicines, the European Medicines Agency is…
STAT+: Pharmalittle: Sanders wants to replace drug patents with prizes for innovation; FDA approves an anthrax vaccine
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Bernie Sanders wants to replace drug patents with prizes for breakthrough medicines
WASHINGTON — Sen. Bernie Sanders (I-Vt.) will finally get a study of his proposal to…
STAT+: Damages from tornado at Pfizer plant could compound challenges of drug shortages
The tornado that struck parts of North Carolina on Wednesday not only damaged the immediate…
STAT+: Pharmalittle: Health care mergers facing tougher antitrust scrutiny; tornado hits Pfizer plant and more shortages may result
Top of the morning to you. And a steamy one, it is. In fact, there…
STAT+: FTC plans to reverse years of policy statements supporting pharmacy benefit managers
The U.S. Federal Trade Commission is reversing years of prior advocacy in support of pharmacy…
STAT+: House committee probes FDA inspections of pharma plants in China and India
A Congressional committee is demanding the U.S. Food and Drug Administration provide detailed information about…
STAT+: Pharmalittle: J&J is third drugmaker to sue over Medicare negotiations; Teva faces trial over Medicare kickbacks
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT+: App developer Twill hunts for pharma partner to market its digital depression treatment
In another sign of the business headwinds facing prescription mental health apps, developer Twill will…
STAT+: Bernie Sanders adds three drug shortage policies to pandemic preparedness bill
WASHINGTON — Senate health committee Chair Bernie Sanders added three drug shortage measures to a…
STAT+: At Orexo, a ‘turning point’ for everything but digital health
Most everything is looking up for Orexo, the company reported on its second quarter earnings…
STAT+: Johnson & Johnson sues to stop Medicare negotiation
WASHINGTON — Pharmaceutical giant Johnson & Johnson on Tuesday became the third drugmaker to sue the…
STAT+: Novartis is scolded by U.K. trade group for the third time this year over Entresto marketing
For the third time this year, Novartis has been rebuked by a U.K. trade group…
STAT Virtual Event: The State of Biosimilars: What to Watch
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET. Now…
STAT+: Pharmalittle: Data confirm benefits and risks of Lilly Alzheimer’s drug; Medicare aims to pay hospitals to stockpile essential drugs
Rise and shine, everyone, another busy day is on the way. We can tell because…
STAT+: Colombian government explores compulsory licensing for an HIV drug
The latest clash over the cost of a prescription medicine is playing out in Colombia,…
STAT+: Pharmalittle: Alzheimer’s diagnosis revamp embraces rating scale similar to cancer; FTC seeks info on Pfizer-Seagen deal
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
J&J expands global access to TB drug as popular novelist joins advocacy campaign
Advocates have been fighting Johnson & Johnson for years over a patent on a lifesaving…
STAT+: Eli Lilly to acquire Versanis in heated race for weight loss drugs
Eli Lilly said Friday it will acquire Versanis Bio, a private company developing an obesity…
STAT+: Pharmalittle: Key Senate panel has a plan for PBMs; Roivant eyes $7 billion sale of a stomach drug
And so, another working week will soon draw to a close. Not a moment too…
STAT+: HHS leader to vaccine makers: Set ‘reasonable’ prices for your next round of Covid-19 vaccines
Amid ongoing controversy over the cost of medicines, a key Biden administration official told Covid-19…
FDA approves first over-the-counter birth control pill
In a highly anticipated move, the U.S. Food and Drug Administration approved the first over-the-counter…
STAT+: Pharmalittle: Congress is letting a drug shortages fix pass it by; FDA voucher program may lapse in October
Rise and shine, folks, another busy day is on the way. Already, there was a…
STAT+: Pharmalittle: EU fines Illumina $475M for closing Grail deal; life-threatening lead poisoning antidote in short supply
Hello, everyone, and how are you this fine, sunny morning? The middle of the week…
STAT+: How to ‘break the logjam’? Economists pitch a plan to curb dire drug shortages
There are alarmingly frequent reports of shortages of vitally needed medicines. From tablets to treat…
Superbugs, antibiotic resistance get renewed scrutiny in Congress
Melanie Lawrence doesn’t think she’ll live long enough to see her son graduate college. Lawrence,…
STAT+: Pharmalittle: Eisai exec who helped lead Alzheimer’s drug development to retire; Express Scripts adds three Humira biosimilars to preferred formulary
Top of the morning to you, and a fine one it is. Birds are chirping…
STAT+: Pharmalittle: European regulator probes suicidal risks of weight loss drugs; Pfizer reports shortages of penicillin for fighting syphilis
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: House panel expected to mark up pandemic-preparedness bill next week
WASHINGTON — A House subcommittee will next week mark up a package of public health…
STAT+: Pharmalittle: FDA grants full approval to Alzheimer’s drug; Sanders blocks NIH nominee over drug costs
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Generic group sues Minnesota over a drug pricing transparency law it calls an “unconstitutional overreach”
The trade group for generic drug companies has filed a lawsuit alleging a Minnesota law…
STAT+: Pharmalittle: Next big hope for Alzheimer’s might not help most Black patients; drugmakers ask Supreme Court to toss terrorism-support ruling
Top of the morning to you, and a fine one it is. Cool breezes and…
STAT+: With some savvy bets, a dynamic duo makes Eli Lilly one of pharma’s biggest success stories
The partnership that would shape Eli Lilly into one of the biggest success stories in…
STAT+: NIH halts funding for Colombian facilities accused of abusing animals
The U.S. National Institutes of Health late last month halted funding for a pair of…
STAT+: Pharmalittle: Novo Nordisk spent $11 million on doctors to promote Ozempic and similar drugs; China offers foreign drugmakers an olive branch
Good morning, everyone, and nice to see you again after an extended holiday break, at…
STAT+: Novo Nordisk bought prescribers over 450,000 meals and snacks to promote drugs like Ozempic
WASHINGTON – Novo Nordisk spent $11 million on meals and travel for thousands of doctors…
STAT+: AstraZeneca shares fall after lung cancer drug underwhelms in trial
LONDON — AstraZeneca said on Monday that a new lung cancer treatment outperformed standard-of-care chemotherapy…
STAT+: Gilead and Teva defeat antitrust lawsuit that claimed prices for HIV medicines were unfairly kept high
In a setback to AIDS activists, a federal court jury on Friday cleared Gilead Sciences…
STAT+: Pharmalittle: FDA approves BioMarin gene therapy for hemophilia A; former Pfizer worker charged with insider trading
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Medicare details the structure of its new drug price negotiation program
WASHINGTON — Medicare on Friday released new details about how its new drug price negotiation…
For Duchenne moms who pushed for cures, new breakthrough therapy can’t rebuild what’s lost
Pat Furlong was sitting in her home office in Middletown, Ohio, last Thursday, refreshing a…
STAT+: Former Pfizer statistician is charged with insider trading over Paxlovid clinical trial results
A former Pfizer statistician on Thursday was charged by U.S. authorities with insider trading for…
STAT+: Pharmalittle: Drug-wholesaler owner indicted for alleged role in diverting HIV medicines; Catalent linked to Regeneron drug rejection
Top of the morning to you. A delicious cool breeze and shiny sun are hovering…
STAT+: Drug wholesaler owner indicted for role in diverting Gilead and J&J HIV medicines
The owner of a pharmaceutical wholesaler has been indicted for his alleged role in distributing…